Intrinsiqq
Iradimed Corp logo

Iradimed Corp (IRMD) Insider Trading

Last 12 months

Insiders sold $19.2M and bought nothing on the open market.

82% of the selling was scheduled in advance under 10b5-1 plans. CHIEF FINANCIAL OFFICER John Glenn sold $1.46M on Dec 11, 2025, 64% of their stake, outside a plan. The last open-market buy by an executive or director was in Mar 2018.

Net open-market
−$19.2M
0 buys · 35 sales
Under a 10b5-1 plan
82%
of the value sold
Insiders who bought / sold
0 / 5
executives and directors
Last open-market buy
Mar 2018
Mar 16, 2018

Get an email when IRMD's executives or directors buy, or make a large sale outside a plan.

Trades · last 2 years

  • Sep 3No plan
    Monty K Allen
    Director · sold 1,419 at avg $86.41
    $123k
    6.8% of stake
  • Jun 4No plan
    Hilda Frederique Scharen-Guivel
    Director · sold 3,000 at avg $95.00
    $285k
    35% of stake
  • Jun 110b5-1 plan
    Roger E. Susi
    CEO, President, Chairman · sold 2,500 at avg $90.60
    $227k
    <0.1% of stake
  • May 26 – 2710b5-1 plan
    Roger E. Susi
    CEO, President, Chairman · sold 7,500 at avg $92.14
    $691k
    0.3% of stake
  • May 18 – 1910b5-1 plan
    Roger E. Susi
    CEO, President, Chairman · sold 7,500 at avg $87.64
    $657k
    0.2% of stake
  • May 11 – 1210b5-1 plan
    Roger E. Susi
    CEO, President, Chairman · sold 7,500 at avg $84.18
    $631k
    0.2% of stake
  • May 4 – 510b5-1 plan
    Roger E. Susi
    CEO, President, Chairman · sold 7,500 at avg $85.71
    $643k
    0.2% of stake
  • Apr 27 – 2810b5-1 plan
    Roger E. Susi
    CEO, President, Chairman · sold 7,500 at avg $87.69
    $658k
    0.2% of stake
  • Apr 20 – 2110b5-1 plan
    Roger E. Susi
    CEO, President, Chairman · sold 7,500 at avg $92.55
    $694k
    0.2% of stake
  • Apr 13 – 1410b5-1 plan
    Roger E. Susi
    CEO, President, Chairman · sold 7,500 at avg $92.96
    $697k
    0.2% of stake
  • Apr 6 – 710b5-1 plan
    Roger E. Susi
    CEO, President, Chairman · sold 7,500 at avg $95.63
    $717k
    0.2% of stake
  • Mar 3010b5-1 plan
    Roger E. Susi
    CEO, President, Chairman · sold 7,500 at avg $95.02
    $713k
    0.2% of stake
  • Mar 23 – 2410b5-1 plan
    Roger E. Susi
    CEO, PRESIDENT, CHAIRMAN · sold 7,500 at avg $100.35
    $753k
    0.2% of stake
  • Mar 16 – 1710b5-1 plan
    Roger E. Susi
    CEO, PRESIDENT, CHAIRMAN · sold 7,500 at avg $101.73
    $763k
    0.2% of stake
  • Mar 9 – 1010b5-1 plan
    Roger E. Susi
    CEO, PRESIDENT, CHAIRMAN · sold 7,500 at avg $100.06
    $750k
    0.2% of stake
  • Mar 610b5-1 plan
    Roger E. Susi
    CEO, PRESIDENT, CHAIRMAN · sold 7,500 at avg $98.39
    $738k
    0.2% of stake
  • Feb 13No plan
    Monty K Allen
    Director · sold 1,000 at $100.26
    $100k
    4.5% of stake
  • Jan 2610b5-1 plan
    Roger E. Susi
    CEO, PRESIDENT, CHAIRMAN · sold 5,000 at avg $100.65
    $503k
    0.1% of stake
  • Jan 2010b5-1 plan
    Roger E. Susi
    CEO, PRESIDENT, CHAIRMAN · sold 5,000 at avg $101.84
    $509k
    0.1% of stake
  • Jan 1210b5-1 plan
    Roger E. Susi
    CEO, PRESIDENT, CHAIRMAN · sold 5,000 at avg $97.45
    $487k
    0.1% of stake
  • Jan 510b5-1 plan
    Roger E. Susi
    CEO, PRESIDENT, CHAIRMAN · sold 5,000 at avg $97.68
    $488k
    0.1% of stake
  • Dec 29, 202510b5-1 plan
    Roger E. Susi
    CEO, PRESIDENT, CHAIRMAN · sold 5,000 at avg $97.66
    $488k
    0.1% of stake
  • Dec 22, 202510b5-1 plan
    Roger E. Susi
    CEO, PRESIDENT, CHAIRMAN · sold 5,000 at avg $96.73
    $484k
    0.1% of stake
  • Dec 15, 202510b5-1 plan
    Roger E. Susi
    CEO, PRESIDENT, CHAIRMAN · sold 5,000 at avg $96.75
    $484k
    0.1% of stake
  • Dec 11, 2025No plan
    John Glenn
    CHIEF FINANCIAL OFFICER · sold 15,000 at avg $97.29
    $1.46M
    64% of stake
  • Dec 9, 2025No plan
    James B Hawkins
    Director · sold 3,000 at $96.61
    $290k
    9.5% of stake
  • Dec 8, 202510b5-1 plan
    Roger E. Susi
    CEO, PRESIDENT, CHAIRMAN · sold 5,000 at avg $95.43
    $477k
    0.1% of stake
  • Dec 1, 202510b5-1 plan
    Roger E. Susi
    CEO, PRESIDENT, CHAIRMAN · sold 5,000 at avg $92.76
    $464k
    0.1% of stake
  • Nov 24, 202510b5-1 plan
    Roger E. Susi
    CEO, PRESIDENT, CHAIRMAN · sold 5,000 at avg $90.36
    $452k
    0.1% of stake
  • Nov 20, 2025No plan
    James B Hawkins
    Director · sold 3,000 at avg $88.24
    $265k
    8.9% of stake
  • Nov 18, 202510b5-1 plan
    Roger E. Susi
    CEO, PRESIDENT, CHAIRMAN · sold 5,000 at avg $85.59
    $428k
    0.1% of stake
  • Nov 10, 202510b5-1 plan
    Roger E. Susi
    CEO, PRESIDENT, CHAIRMAN · sold 5,000 at avg $85.24
    $426k
    0.1% of stake
  • Nov 10, 2025No plan
    John Glenn
    CHIEF FINANCIAL OFFICER · sold 10,651 at $84.51
    $900k
    81% of stake
  • Nov 3, 202510b5-1 plan
    Roger E. Susi
    CEO, PRESIDENT, CHAIRMAN · sold 5,000 at avg $82.64
    $413k
    0.1% of stake
  • Oct 27, 202510b5-1 plan
    Roger E. Susi
    CEO, PRESIDENT, CHAIRMAN · sold 5,000 at avg $77.69
    $388k
    0.1% of stake
  • Oct 21, 202510b5-1 plan
    Roger E. Susi
    CEO, PRESIDENT, CHAIRMAN · sold 5,000 at avg $74.82
    $374k
    0.1% of stake
  • Oct 13, 202510b5-1 plan
    Roger E. Susi
    CEO, PRESIDENT, CHAIRMAN · sold 5,000 at avg $72.59
    $363k
    0.1% of stake
  • Oct 6, 202510b5-1 plan
    Roger E. Susi
    CEO, PRESIDENT, CHAIRMAN · sold 5,000 at avg $71.72
    $359k
    0.1% of stake
  • Oct 1, 202510b5-1 plan
    Roger E. Susi
    CEO, PRESIDENT, CHAIRMAN · sold 5,000 at avg $70.19
    $351k
    0.1% of stake
  • Sep 23, 202510b5-1 plan
    Roger E. Susi
    CEO, PRESIDENT, CHAIRMAN · sold 5,000 at $71.26
    $356k
    0.1% of stake
How to read this. Insiders sell for many reasons: taxes, diversifying, a house. Open-market buys are rarer and say more. A 10b5-1 plan is a trading schedule set up months in advance, so those sales were not timed on news. Large holders (funds and 10% owners) are listed under Everything but not counted as insiders. If you own or watch IRMD, we send a push when an executive buys or makes a large sale outside a plan.

Source: SEC Form 4 filings, filed within two business days of each trade and checked for new ones every hour.

Related stocks: Surgical & Medical Instruments & Apparatus

Spot a number that looks wrong? Check it in IRMD's SEC filings or

Download this analysis as a PDF (Pro)

Data sourced from SEC EDGAR filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.

2 of 2 free stocks used today

Keep analysing IRMD

Create a free account and get 14 days of Premium: every stock and every tool.

  • Unlimited stocks
  • Stock screener
  • Portfolio tracker
  • Editable DCF
  • Compare side by side
  • Unlimited alerts

No card. Moves to Free after, unless you upgrade.

Already have an account?

Or come back tomorrow. Stocks on your watchlist are always free to view.

SectorsPrivacyTerms© 2026 Intrinsiqq

Not financial advice. Analytical data for research only.

Intrinsiqq is a Netherlands-based company operating in Rotterdam, KvK 73238007.